Sentences with phrase «lung cancer patients as»

Everyone wants to point fingers at lung cancer patients as though to ask, «What did you expect to happen?»

These results should support the idea that IMRT is the radiation therapy of choice for lung cancer patients as well.

Not exact matches

She spoke at Genentech, a cancer research firm, exchanged e-mails with half a dozen other cancer patients nationwide and was interviewed on NPR as a voice of nonsmoker lung - cancer sufferers.

The proportion of patients treated within 62 days of an urgent GP referral for various cancer types is as follows: Lung cancers — 83.3 % treated within 62 days of an urgent GP referral for suspected cancer.

The study has been tested in metastatic patients with different primary tumours such as breast, colon and lung cancer.

«What is particularly encouraging is that we are now able to select, based on features in the tumor, approximately a quarter of advanced lung cancer patients who can receive immunotherapy as their initial treatment.

Led by associate professor of pathology and Yale Cancer Center member Don Nguyen, PhD, the researchers analyzed RNA from patients with disease that was limited to the lungs as well as cancers that had spread.

«There has been a tremendous effort over the past several years to block EGFR as a treatment for lung cancer, but this therapy only works in a small subset of patients.

These studies enrolled a total of 12,361 patients diagnosed with a variety of cancers, including lung, breast, skin, and prostate, as well as blood cancers such as leukemia, lymphoma, and myeloma.

Key findings in this study show that 5 - year survival for older lung cancer surgery patients is favorable; surgeons will be able to better individualize care for older lung cancer patients based on newly and uniquely linked data, and the prevalence of lung cancer is expected to increase as the population continues to age.

Fewer than half of all patients who undergo surgery for lung cancer survive as long as 5 years.

«Our findings suggest that this new drug combination would also help patients with this type of aggressive breast cancer as well as other cancers, such as lung, prostate and ovarian cancers,» Dr. Rassool says.

«This greater than expected survival in older patients selected for operative therapy is noteworthy,» said Dr. Fernandez, «especially considering that the prevalence of lung cancer is expected to increase as the population continues to grow older and more people survive into old age.»

The approach is already routine for some cancer patients, such as women and men with breast cancer tumors that have high levels of a protein called HER2, or lung cancer tumors with mutations in the EGFR gene.

This will establish sequential crizotinib followed by a second generation ALK inhibitor as the standard treatment for patients with metastatic ALK positive lung cancer.»

In one of the new papers, Zitvogel's group examined data for 249 lung, kidney, and bladder cancer patients, 69 of whom took antibiotics for routine reasons such as dental work or a urinary tract infection before or soon after starting a PD - 1 drug.

As a result, this group succeeded in isolating ORs which respond to three types of volatile organic compounds (2 - pentanone, pyridine, 2 - butanone) respectively in urine samples from lung cancer patients.

This shows promise for breast cancer patients as diagnosing and treating the breast cancer at early stages means there is a greater chance of preventing cancer cells spreading to other tissues, such as the lungs, brain and bone.

«As the population of the United States ages, there will be a higher number of lung cancer patients with comorbidities at diagnosis.»

Certain diseases, such as lung cancer, can cause patients to give off particular smells; dogs have been known to detect these, and a bioelectronic nose opens the path to diagnosis through smell.

The same benefits of increased activity observed in lung cancer patients, especially improved symptoms and quality of life, appear to apply to lung cancer survivors as well.

Perioperative exercise in lung cancer patients appears to be safe with improvement in operability, operative risk, post-operative complications, as well as increase exercise capacity.

Results of an initial study of tumors from patients with lung cancer or head and neck cancer suggest that the widespread acquired resistance to immunotherapy drugs known as checkpoint inhibitors may be due to the elimination of certain genetic mutations needed to enable the immune system to recognize and attack malignant cells.

Clinical trials found that it is safe to regularly infuse brain and lung cancer patients with 800 — 1000 times the daily recommended amount of vitamin C as a potential strategy to improve outcomes of standard cancer treatments.

Perera began working with Weinstein on a small study comparing two groups of hospital patients: One group was suffering from lung cancer; the other was a group of orthopedic patients as a control sample.

Most lung cancer patients undergo 4D CT as standard - of - care to help radiation oncologists develop a personalized plan to account for breathing motion during therapy.

It doesn't kill the cell that it hides in, but is dangerous enough that it can cause infections in individuals with an impaired immune system, such as patients who are receiving cancer treatment, who have pre-existing lung problems or whose immune systems are otherwise compromised.

Alice Shaw recalls a signal moment in 2004 — just as she was finishing her oncology fellowship at MIT — when scientists discovered that mutations in a gene for epidermal growth factor receptor (EGFR) were the culprits in about 10 to 15 percent of lung cancer patients.

The drugs are already approved for treatment of patients with advanced breast cancer as well as ovarian, pancreatic and certain lung cancers.

«More and more patients are being cured of lung cancer, with both surgery and radiation as good treatment options,» said lead author Nirav S. Kapadia, MD, of Dartmouth - Hitchcock Medical Center in New Hampshire.

ARandomized, Phase III, Double - Blind Placebo - Controlled Trial of Sunitinib as Maintenance Therapy in Non-Progressing Patients following an Initial Four Cycles of Platinum - Based Combination Chemotherapy in Advanced, Stage IIIB / IV Non-Small Cell Lung Cancer

On October 2, 2015, the FDA approved the immunotherapy drug pembrolizumab (Keytruda ®), made by Merck, as second - line treatment for patients with lung cancer, the leading cause of cancer - related death in the U.S. and the world.

One of the major parameters was the safety of these agents in the respiratory airways and lung parenchyma, since several of these agents are known to cause adverse effects.23 The main adverse effects observed were cough, transient fever and transient decrease in the respiratory functions after the aerosol administration.8, 19, 20 Moreover; it has been observed that excessive deposition of these agents in one site of the respiratory system can induce non-specific side effects in the form of pulmonary edema as observed with many other drugs.16 These side effects were milder when a premedication with bronchodilators and inhaled corticosteroids were administered.8, 19, 20 Until now no long term trial (> 9 months) has been performed since all patients included in previous studies had stage IV non-small cell lung cancer (NSCLC).

Lung cancer treatment is an evolving field of science, currently there are several pathways under investigation as a possible treatment target.1 - 3 Targeted treatment is currently considered to be more efficient compared to the non-specific cytotoxic drugs, however; the small number of patients identified with mutations, limit the application of these drugs.

Short Research Communication The Factors Reducing Relative Dose Intensity of Cisplatin and Vinorelbine as Adjuvant Chemotherapy in Patients with Non-Small Cell Lung Cancer Ryo Inose, Katsuyuki Takahashi, Naruo Yoshimura, Tomoya Kawaguchi, Mitsutaka Takada, Katsuya Nagayama Oncomedicine 2018; 3: 9 - 14.

«The IASLC, being a global, multidisciplinary organization, is uniquely positioned to coordinate a harmonized strategy that can bring people together to show how the culture of lung cancer should reflect hope, as advances in lung cancer screening and early detection, personalized therapies, and immunotherapies are making a real impact in patients» lives.»

The work that garnered the honor, «An analysis of the risk and benefit of neoadjuvant chemotherapy among patients undergoing surgery for non-small cell lung cancer,» examined data from more than 134,000 patients in the National Cancer Database to assess the impact of neoadjuvant therapy on perioperative outcomes, as well as long - term surcancer,» examined data from more than 134,000 patients in the National Cancer Database to assess the impact of neoadjuvant therapy on perioperative outcomes, as well as long - term surCancer Database to assess the impact of neoadjuvant therapy on perioperative outcomes, as well as long - term survival.

While «ROS1 fusion» has primarily been studied in lung cancer, the Global ROS1 Initiative includes ROS1 - positive (ROS1 +) patients with melanoma and pancreatic cancer as well.

We are excited to evaluate our technology in combination with pembrolizumab as a potential treatment for lung cancer, and about the promise it may hold for patients,» said Turnstone CEO Sammy Farah, PhD.

Inform and educate clinicians as to updates and revisions of their Molecular testing Guideline for the Selection of Lung cancer Patients for Treatment with Targeted Tyrosine Kinase Inhibitors.

Patients with insulin resistance and obesity, conditions characterized by high insulin levels are at high risk of all sorts of common cancers such as lung and colorectal.

Studies involving patients with cancer such as lung or breast cancer show that dogs can pin - point the scent of biochemical markers by sniffing people's breath and alerting researchers that they smell the cancer.

Mesothelioma is a form of cancer affecting the linings of certain internal body organs of a patient, such as the lungs, heart and chest cavity, and has been linked to asbestos exposure earlier in the life of the patient.

MBSR (supplementary to care - as - usual) has been shown to be effective in reducing stress levels and improving quality of life in patients with lung cancer (Schellekens et al., 2017).